先天性甲状腺功能减退症的遗传学与临床管理:以患者为中心的方法
本文以临床案例为框架,阐述遗传学信息在先天性甲状腺功能减退症(CH)诊断、治疗和咨询中的实际应用。文章聚焦于何时进行基因检测、结果如何影响治疗时长与强度,以及如何指导预后和家庭咨询,强调务实且以患者为中心的管理策略。
要点
- 遗传学检测可辅助CH的病因诊断与预后判断
- 基因结果有助于个体化决定治疗时长与强度
- 遗传信息应整合于家庭咨询与长期管理决策中
核心结论
- 遗传学信息可 substantiate CH 的诊断、管理及咨询,但需以务实、患者为中心的方式应用。
研究设计与样本
- 本文为以临床案例(vignettes)为基础的叙述性方法学文章,非系统性遗传综述。
主要发现
- CH涵盖从暂时性新生儿高促甲状腺素血症到永久性甲状腺激素或促甲状腺素缺乏的 diverse 谱系。
- 分子遗传学进展大幅扩展了CH相关基因目录,但转化至日常临床仍具挑战。
临床怎么用
- 临床中应聚焦于基因检测时机的选择、结果对治疗时长与强度的指导,以及预后判断和家庭咨询。
局限性
- 本文未提供 exhaustive 遗传学综述,仅基于 selected 临床案例讨论相关场景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Congenital hypothyroidism (CH) encompasses a diverse spectrum of disorders with diverse genetic etiologies and variable clinical courses, ranging from transient neonatal hyperthyrotropinemia to permanent thyroid hormone or thyrotropin deficiency. Advances in molecular genetics have substantially expanded the catalog of genes implicated in CH; however, the translation of this knowledge into everyday clinical practice remains challenging. In this Approach to the Patient, we use selected clinical vignettes to illustrate how genetic information can substantiate the diagnosis, management, and counseling of patients with CH. Rather than providing an exhaustive genetic review, this paper focuses on clinically relevant scenarios and pragmatic decision points-when to perform genetic testing, how results influence treatment duration and intensity, and how they guide prognostication and family counseling. This case-based framework emphasizes a pragmatic, patient-centered approach to the use of genetics in the management of CH.
引用
- Nguyen Quoc A, Kariyawasam D, Polak M, et al. Approach to the patient: genetics and management of congenital hypothyroidism. J Clin Endocrinol Metab. 2026. PMID: 42170892. doi:10.1210/clinem/dgag215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。